AAAAAA

   
Results: 1-23 |
Results: 23
VIROLOGICAL AND CLINICAL IMPLICATIONS OF RESISTANCE TO HIV-I PROTEASEINHIBITORS
Authors: CONDRA JH
Citation: Jh. Condra, VIROLOGICAL AND CLINICAL IMPLICATIONS OF RESISTANCE TO HIV-I PROTEASEINHIBITORS, DRUG RESISTANCE UPDATES, 1(5), 1998, pp. 292-299
RESISTANCE TO HIV PROTEASE INHIBITORS
Authors: CONDRA JH
Citation: Jh. Condra, RESISTANCE TO HIV PROTEASE INHIBITORS, Haemophilia, 4(4), 1998, pp. 610-615
SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP
Authors: GULICK RM MELLORS JW HAVLIR D ERON JJ GONZALEZ C MCMAHON D JONAS L MEIBOHM A HOLDER D SCHLEIF WA CONDRA JH EMINI EA ISAACS R CHODAKEWITZ JA RICHMAN DD
Citation: Rm. Gulick et al., SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP, JAMA, the journal of the American Medical Association, 280(1), 1998, pp. 35-41
RESISTING RESISTANCE - MAXIMIZING THE DURABILITY OF ANTIRETROVIRAL THERAPY
Authors: CONDRA JH
Citation: Jh. Condra, RESISTING RESISTANCE - MAXIMIZING THE DURABILITY OF ANTIRETROVIRAL THERAPY, Annals of internal medicine, 128(11), 1998, pp. 951-954
CLINICALLY EFFECTIVE HIV-1 PROTEASE INHIBITORS
Authors: VACCA JP CONDRA JH
Citation: Jp. Vacca et Jh. Condra, CLINICALLY EFFECTIVE HIV-1 PROTEASE INHIBITORS, Drug discovery today, 2(7), 1997, pp. 261-272
CRIXIVAN(R) - A POTENT INHIBITOR OF HIV-1 PROTEASE IN-VIVO
Authors: HUFF JR VACCA JP DORSEY BD EMINI EA CONDRA JH SCHLEIF WA MASSARI FE DEUTSCH PJ CHODAKEWITZ J KUO LC CHEN Z
Citation: Jr. Huff et al., CRIXIVAN(R) - A POTENT INHIBITOR OF HIV-1 PROTEASE IN-VIVO, The FASEB journal, 11(9), 1997, pp. 23-23
GENETIC CORRELATES OF IN-VIVO VIRAL RESISTANCE TO INDINAVIR, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR
Authors: CONDRA JH HOLDER DJ SCHLEIF WA BLAHY OM DANOVICH RM GABRYELSKI LJ GRAHAM DJ LAIRD D QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M YANG T CHODAKEWITZ JA DEUTSCH PJ LEAVITT RY MASSARI FE MELLORS JW SQUIRES KE STEIGBIGEL RT TEPPLER H EMINI EA
Citation: Jh. Condra et al., GENETIC CORRELATES OF IN-VIVO VIRAL RESISTANCE TO INDINAVIR, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Journal of virology, 70(12), 1996, pp. 8270-8276
CORRELATION BETWEEN GENOTYPIC EVIDENCE OF HIV-1 RESISTANCE TO THE PROTEASE INHIBITOR MK-639 AND LOSS OF ANTIRETROVIRAL EFFECT IN TREATED PATIENTS
Authors: MELLORS JW MCMAHON DK CHODAKEWITZ JA SCHLEIF WA EMINI EA CONDRA JH
Citation: Jw. Mellors et al., CORRELATION BETWEEN GENOTYPIC EVIDENCE OF HIV-1 RESISTANCE TO THE PROTEASE INHIBITOR MK-639 AND LOSS OF ANTIRETROVIRAL EFFECT IN TREATED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 71-71
DYNAMICS OF ACQUIRED HIV-1 CLINICAL RESISTANCE TO THE PROTEASE INHIBITOR MK-639
Authors: CONDRA JH SCHLEIF WA BLAHY OM GABRYELSKI LJ GRAHAM DJ QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M TITUS D YANG T ZHANG J CHODAKEWITZ JA DEUTSCH PJ EMINI EA
Citation: Jh. Condra et al., DYNAMICS OF ACQUIRED HIV-1 CLINICAL RESISTANCE TO THE PROTEASE INHIBITOR MK-639, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 72-72
EVIDENCE FOR THE EXISTENCE OF LONG-LIVED GENETIC RESERVOIRS OF HIV-1 IN INFECTED PATIENTS
Authors: CONDRA JH SCHLEIF WA BLAHY OM GABRYELSKI LJ GRAHAM DJ QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M TITUS D YANG T ZHANG J DEUTSCH PJ SQUIRES KE EMINI EA
Citation: Jh. Condra et al., EVIDENCE FOR THE EXISTENCE OF LONG-LIVED GENETIC RESERVOIRS OF HIV-1 IN INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 82-82
IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS
Authors: CONDRA JH SCHLEIF WA BLAHY OM GABRYELSKI LJ GRAHAM DJ QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M TITUS D YANG T TEPPLER H SQUIRES KE DEUTSCH PJ EMINI EA
Citation: Jh. Condra et al., IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS, Nature, 374(6522), 1995, pp. 569-571
PURIFICATION AND CHARACTERIZATION OF HIV-1 REVERSE-TRANSCRIPTASE HAVING A 1 1-RATIO OF P66 AND P51 SUBUNITS/
Authors: STAHLHUT M LI Y CONDRA JH FU J GOTLIB L GRAHAM DJ OLSEN DB
Citation: M. Stahlhut et al., PURIFICATION AND CHARACTERIZATION OF HIV-1 REVERSE-TRANSCRIPTASE HAVING A 1 1-RATIO OF P66 AND P51 SUBUNITS/, Protein expression and purification, 5(6), 1994, pp. 614-621
MUTATIONS IN HIV-1 PROTEASE RESIDUES AFFECTING SUSCEPTIBILITY TO L-735,524
Authors: CONDRA JH BLAHY OM BUSH BL CULBERSON C GOTLIB L GRAHAM DJ GRAHAM PL HOLLOWAY MK LAFEMINA RL QUINTERO JC RHODES A ROTH E SARDANA VV SCHNEIDER CL SCHLABACH AJ SCHLEIF WA TITUS DL WOLANSKI BS WOLFGANG JA EMINI EA
Citation: Jh. Condra et al., MUTATIONS IN HIV-1 PROTEASE RESIDUES AFFECTING SUSCEPTIBILITY TO L-735,524, Journal of cellular biochemistry, 1994, pp. 166-166
THE GENETIC AND FUNCTIONAL BASIS OF HIV-1 RESISTANCE TO NONNUCLEOSIDEREVERSE-TRANSCRIPTASE INHIBITORS
Authors: EMINI EA BYRNES VW CONDRA JH SCHLEIF WA SARDANA VV
Citation: Ea. Emini et al., THE GENETIC AND FUNCTIONAL BASIS OF HIV-1 RESISTANCE TO NONNUCLEOSIDEREVERSE-TRANSCRIPTASE INHIBITORS, Archives of virology, 1994, pp. 11-17
SUSCEPTIBILITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENZYME AND VIRAL VARIANTS EXPRESSING MULTIPLE RESISTANCE-ENGENDERING AMINO-ACID SUBSTITUTIONS TO REVERSE-TRANSCRIPTASE INHIBITORS
Authors: BYRNES VW EMINI EA SCHLEIF WA CONDRA JH SCHNEIDER CL LONG WJ WOLFGANG JA GRAHAM DJ GOTLIB L SCHLABACH AJ WOLANSKI BS BLAHY OM QUINTERO JC RHODES A ROTH E TITUS DL SARDANA VV
Citation: Vw. Byrnes et al., SUSCEPTIBILITIES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENZYME AND VIRAL VARIANTS EXPRESSING MULTIPLE RESISTANCE-ENGENDERING AMINO-ACID SUBSTITUTIONS TO REVERSE-TRANSCRIPTASE INHIBITORS, Antimicrobial agents and chemotherapy, 38(6), 1994, pp. 1404-1407
L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR
Authors: VACCA JP DORSEY BD SCHLEIF WA LEVIN RB MCDANIEL SL DARKE PL ZUGAY J QUINTERO JC BLAHY OM ROTH E SARDANA VV SCHLABACH AJ GRAHAM PI CONDRA JH GOTLIB L HOLLOWAY MK LIN J CHEN IW VASTAG K OSTOVIC D ANDERSON PS EMINI EA HUFF JR
Citation: Jp. Vacca et al., L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 4096-4100
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS - EVALUATION OF RESISTANCE ENGENDERED BY AMINO-ACID SUBSTITUTIONS IN THE ENZYMES SUBSTRATE-BINDING SITE
Authors: SARDANA VV SCHLABACH AJ GRAHAM P BUSH BL CONDRA JH CULBERSON JC GOTLIB L GRAHAM DJ KOHL NE LAFEMINA RL SCHNEIDER CL WOLANSKI BS WOLFGANG JA EMINI EA
Citation: Vv. Sardana et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS - EVALUATION OF RESISTANCE ENGENDERED BY AMINO-ACID SUBSTITUTIONS IN THE ENZYMES SUBSTRATE-BINDING SITE, Biochemistry, 33(8), 1994, pp. 2004-2010
HIV-1 REVERSE-TRANSCRIPTASE RESIDUES THAT INFLUENCE SENSITIVITY TO NONNUCLEOSIDE INHIBITORS
Authors: BYRNES VW SARDANA VV CONDRA JH SCHLEIF WA SCHNEIDER CL WATERBURY JA WOLFGANG JA GRAHAM DJ GOTLIB L SCHLABACH AJ WOLANSKI BS LONG WJ RHODES A TITUS DL ROTH E BLAHY OM EMINI EA
Citation: Vw. Byrnes et al., HIV-1 REVERSE-TRANSCRIPTASE RESIDUES THAT INFLUENCE SENSITIVITY TO NONNUCLEOSIDE INHIBITORS, Journal of cellular biochemistry, 1993, pp. 75-75
A RAPID SCREEN FOR DRUG-RESISTANT HIV PROTEASE MUTANTS
Authors: CONDRA JH EMINI EA GOTLIB L GRAHAM DJ
Citation: Jh. Condra et al., A RAPID SCREEN FOR DRUG-RESISTANT HIV PROTEASE MUTANTS, Journal of cellular biochemistry, 1993, pp. 76-76
COMPREHENSIVE MUTANT ENZYME AND VIRAL VARIANT ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE RESISTANCE TO NONNUCLEOSIDE INHIBITORS
Authors: BYRNES VW SARDANA VV SCHLEIF WA CONDRA JH WATERBURY JA WOLFGANG JA LONG WJ SCHNEIDER CL SCHLABACH AJ WOLANSKI BS GRAHAM DJ GOTLIB L RHODES A TITUS DL ROTH E BLAHY OM QUINTERO JC STASZEWSKI S EMINI EA
Citation: Vw. Byrnes et al., COMPREHENSIVE MUTANT ENZYME AND VIRAL VARIANT ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE RESISTANCE TO NONNUCLEOSIDE INHIBITORS, Antimicrobial agents and chemotherapy, 37(8), 1993, pp. 1576-1579
A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR ACTIVE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO RELATED INHIBITORS
Authors: GOLDMAN ME OBRIEN JA RUFFING TL SCHLEIF WA SARDANA VV BYRNES VW CONDRA JH HOFFMAN JM EMINI EA
Citation: Me. Goldman et al., A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR ACTIVE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES RESISTANT TO RELATED INHIBITORS, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 947-949
HIV AND MULTIDRUG-RESISTANCE
Authors: EMINI EA GRAHAM DJ GOTLIB L CONDRA JH BYRNES VW SCHLEIF WA
Citation: Ea. Emini et al., HIV AND MULTIDRUG-RESISTANCE, Nature, 364(6439), 1993, pp. 679-679
5-CHLORO-3-(PHENYLSULFONYL)INDOLE-2-CARBOXAMIDE - A NOVEL, NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE
Authors: WILLIAMS TM CICCARONE TM MACTOUGH SC ROONEY CS BALANI SK CONDRA JH EMINI EA GOLDMAN ME GREENLEE WJ KAUFFMAN LR OBRIEN JA SARDANA VV SCHLEIF WA THEOHARIDES AD ANDERSON PS
Citation: Tm. Williams et al., 5-CHLORO-3-(PHENYLSULFONYL)INDOLE-2-CARBOXAMIDE - A NOVEL, NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE, Journal of medicinal chemistry, 36(9), 1993, pp. 1291-1294
Risultati: 1-23 |